Skip to content
HowShorted

EyePoint, Inc. short interest in 2023

In 2023, EyePoint, Inc.'s disclosed short interest ran from 5.92% of shares outstanding on 13 Jan 2023 to 15.10% on 29 Dec 2023, a change of +9.18 percentage points. The year's high was 19.85% on 30 Nov 2023 and its low 5.92% on 13 Jan 2023, averaging 12.75% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.70 days on 15 Sep 2023. Full history: EyePoint, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for EyePoint, Inc. in 2023

2023 in figures

Start of year
5.92% (13 Jan 2023)
End of year
15.10% (29 Dec 2023)
Change
+9.18 pp
High
19.85% (30 Nov 2023)
Low
5.92% (13 Jan 2023)
Average
12.75%
Highest days to cover
13.70 (15 Sep 2023)
SEC filings marked
9

Every report in 2023

EyePoint, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20235.92%4.04results (8-K)
31 Jan 20236.34%7.87
15 Feb 20236.07%10.76
28 Feb 20236.08%12.58
15 Mar 20238.19%8.43results (8-K), 10-K filed
31 Mar 20239.79%9.58
14 Apr 202310.70%11.98
28 Apr 202310.62%1.02
15 May 202311.82%8.60results (8-K), 10-Q filed
31 May 202312.41%9.21
15 Jun 202314.07%11.59
30 Jun 202315.11%10.88
14 Jul 202313.94%6.45
31 Jul 202313.93%8.66
15 Aug 202314.44%8.09results (8-K), 10-Q filed
31 Aug 202316.19%8.11
15 Sep 202317.67%13.70
29 Sep 202319.83%13.05
13 Oct 202314.04%13.14
31 Oct 202315.14%11.29
15 Nov 202315.41%10.35results (8-K), 10-Q filed
30 Nov 202319.85%10.17
15 Dec 202313.45%1.02
29 Dec 202315.10%4.70

See also: EyePoint, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.